We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Antibiotic Reduces Cartilage Loss of Arthritis

By HospiMedica staff writers
Posted on 23 Mar 2004
Researchers have found that doxycycline, a common antibiotic, appears to reduce cartilage loss and pain in women whose knees show early signs of osteoarthritis.

A study involving 431 women, aged 45-64, was conducted over a 30-month period in six sites. More...
The participants had x-ray evidence of osteoarthritis in only one knee at the start of the trial but were at very high risk for similar development in the other knee in the near future. Half of the women received a placebo and the other half received 100 mg of doxycycline twice daily. At the end of the trial, x-rays showed that the women who received doxycycline had an average of 33% less cartilage loss in their affected knee, compared to the group who had only placebo. There was also evidence that the antibiotic had a beneficial effect on the unaffected knees. The researchers used fluoroscopy for obtaining the live x-ray images of each patient's knees.

In addition, the results showed that women taking doxycycline were less likely to report "clinically significant increases” in knee pain, said Kenneth D. Brandt, professor of medicine and orthopedic surgery at the Indiana University School of Medicine (Indianapolis, IN, USA; www.medicine.iu.edu). The goal of new research would be to develop a drug that provides a therapy for osteoarthritis without the common side effects of antibiotics.




Related Links:
Indiana U. School of Medicine

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.